Sensitivity of non-clade B primary HIV-1 isolates to mildly acidic pH.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.QAI.0000243048.50451.18PMID 17099316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.

  2006cited by this paper
• Safety and Efficacy Evaluations for Vaginal and Rectal Use of BufferGel in the Macaque Model

  2004cited by this paper
• Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.

  2004cited by this paper
• Considerations and development of topical microbicides to inhibit the sexual transmission of HIV

  2002cited by this paper
• Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites

  2001cited by this paper
• Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.

  2001cited by this paper
• Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models

  2001cited by this paper
• Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM).

  2001cited by this paper
• Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission.

  2001cited by this paper
• Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.

  1999cited by this paper
• Vaginal pH neutralization by semen as a cofactor of HIV transmission.

  1997cited by this paper
• The Activity of Candidate Virucidal Agents, Low pH and Genital Secretions against HIV-1 In Vitro

  1995cited by this paper
• Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system

  1995cited by this paper
• Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin.

  1991cited by this paper
• Acid Sensitivity of Cell-Free and Cell-Associated HIV-1: Clinical Implications

  1990cited by this paper
• Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus.

  1985cited by this paper
• Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus.

  1985cited by this paper

• Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase

  2025cites this paper
• Virus and microbiota relationships in humans and other mammals: An evolutionary view

  2019cites this paper
• Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis

  2015cites this paper
• Influence of Common Mucosal Co‐Factors on HIV Infection in the Female Genital Tract

  2014cites this paper
• HIV transmission models: Lessons learned for microbicide formulation design

  2014cites this paper
• Influence of Mildly Acidic pH Conditions on the Production of Lentiviral and Retroviral Vectors

  2014cites this paper
• Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota

  2013cites this paper
• Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein

  2013cites this paper
• Circumcision and HIV Infection among Men Who Have Sex with Men in Britain: The Insertive Sexual Role

  2013cites this paper
• Vaginal concentrations of lactic acid potently inactivate HIV

  2013cites this paper
• Non-specific microbicide product development: then and now.

  2012cites this paper
• SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans

  2011cites this paper
• New Approaches to Making the Microenvironment of the Female Reproductive Tract Hostile to HIV

  2011cites this paper
• The role of semen in sexual transmission of HIV: beyond a carrier for virus particles.

  2011cites this paper
• Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

  2011cites this paper
• Female Genital Tract Secretions and Semen Impact the Development of Microbicides for the Prevention of HIV and Other Sexually Transmitted Infections

  2011cites this paper
• Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions

  2010cites this paper
• Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells

  2009influential citation
• Preclinical evaluation of lime juice as a topical microbicide candidate

  2008cites this paper
• The Effect of Acids on the Survival of HIV During Drug Injection

  2007influential citation